PCT & Support

Vilfic (Tadalafil) 40 mg Elbrus Pharmaceuticals

Elbrus Pharmaceuticals

35,00

In Stock (100 available)

Vilfic (Tadalafil) 40 mg Elbrus Pharmaceuticals (40 mg) — Manufactured by Elbrus Pharmaceuticals to exacting pharmaceutical standards, tadalafil (Cialis) is a long-acting PDE5 inhibitor pr…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

This Elbrus Pharmaceuticals tadalafil at 40 mg supports both erectile function and BPH management. Muscle/back pain at higher doses is a characteristic side-effect.

Key Benefits

  • PDE5 inhibitor — weekend-long action (~36 hour window)
  • Standard pharmacological ED treatment
  • Low-dose daily use supported by clinical trials
  • Oral dosing, on-demand or daily
  • Side-benefit: prostate-size reduction in BPH
  • Each unit dosed at 40 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Clinical dosing: on-demand 10–20 mg 30 minutes before anticipated activity; daily low-dose 2.5–5 mg/day for sustained coverage. Max 20 mg in any 24-hour period.

How It Works

Selective phosphodiesterase type 5 (PDE5) inhibitor. Prolongs cGMP-mediated smooth-muscle relaxation in penile vasculature. Requires sexual stimulation to trigger NO release — not a spontaneous-erection drug.

Pharmacokinetics

Plasma half-life approximately 17.5 hours — effective window up to 36 hours (“the weekend pill”). Food does not significantly affect absorption (unlike sildenafil).

Potential Side Effects

Headache, flushing, nasal congestion, back/muscle pain, dyspepsia. Never combine with nitrates (life-threatening hypotension). Alpha-blocker interactions require medical oversight. Hearing/vision changes rare but warrant immediate discontinuation.

Cycle & Stacking Guide

On-demand use or daily low-dose. On-cycle AAS users with libido issues from aromatase suppression may benefit from daily 5 mg. Stacks with PT-141 (different mechanisms, additive effect).

Manufacturer Notes

Elbrus Pharmaceuticals is an Eastern European producer with GMP certification. Their pharmacology catalogue is broad, covering AAS, peptides, and harm-reduction supports.

Storage & Handling

Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Vilfic (Tadalafil) 40 mg Elbrus Pharmaceuticals”

Your email address will not be published. Required fields are marked *

Tadalafil

Physical & Chemical Properties for Research Purposes
Chemical structure of Tadalafil (C22H19N3O4) for laboratory analysis
2D structural representation · PubChem CID 110635 ↗
Chemical Identity
# CAS Registry Number 171596-29-5
Σ IUPAC Name (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
F Molecular Formula C22H19N3O4
M Molecular Weight 389.40 g/mol
SMILES CN1CC(=O)N2[C@@H](CC3=C2C4=CC=CC=C4N3)C5=CC6=C(C=C5)OCO6)C1=O
InChIKey WOXKDUGGOYFFRN-IIBYNOLFSA-N
Melting Point 298-300 °C
Solubility Practically insoluble in water; soluble in DMSO
Biological Half-life 17.5 hours (oral)
PubChem CID 110635 ↗
Pharmacological Profile
Aromatization None
Hepatotoxicity Low
Known trade names: Cialis, Adcirca, Vilfic

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.